Thromb Haemost 1963; 10(01): 151-163
DOI: 10.1055/s-0038-1654771
Originalarbeiten — Original Article — Travaux Originaux
Schattauer GmbH

Inactivation of Antiplasmin and Complement C1 in Human Plasma Rendered Fibrinolytic by Synthetic Organic Compounds[*]

Kurt N von Kaulla with the technical assistance of John Eisele and Marlow Ens
1   Department of Medicine, University of Colorado School of Medicine, Denver/Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Summary

Certain synthetic organic compounds induce upon dissolution marked fibrinolytic activity in human plasma, reduce the antiplasmin titer of human or bovine serum and destroy the complement C1 of human plasma. Generation of fibrinolytic activity and reduction of antiplasmin are concentration-depending time reactions. Destruction of complement C1 occurs almost instantaneously. Minor molecular modifications abolish all three activities of the compounds.

* Read in part at the Eleventh Annual Symposion on Blood, Wayne State University, Detroit 1963. Supported by the American Heart Association and in part by the Wyoming Heart Association.


The valuable advice of Dr. David Pearlman, Division of Immunology, Dept. of Medicine, University of Colorado School of Medicine, for complement titrations is gratefully acknowledged.


 
  • References

  • 1 von Kaulla K. N. Chemical structure and fibrinolysis induction in vitro. Studies with 126 compounds. Thrombos. Diathes haemorrh. (Stuttg.) 07: 404 1962;
  • 2 von Kaulla K. N. The chemistry of thrombolysis: Human fibrinolytic enzymes. C. C. Thomas Publisher; Springfield: 1963: 333.
  • 3 Michaelis L. Der Azetatpuffer. Biochem. 2. 234: 139 1931;
  • 4 Mayer M. M. Hemolytic assay of complement. in: Kabat E. A, Mayer M. M. Experimental immunochemistry.. C. C. Thomas; Springfield: 2nd Edition. 1961: 133.
  • 5 von Kaulla K. N, Smith R. L. Urea derivatives as fibrinolysis promoting agents. Proc. Soc. exp. Biol. 106: 530 1961;